RTX Stock Analysis: RTX | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 268.327m USD | 12M Return: 39.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 999M
EPS Trend: 96.8%
Qual. Beats: 1
Rev. Trend: 97.0%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
RTX Corporation is a global aerospace and defense company headquartered in Arlington, Virginia, operating through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. Collins Aerospace provides a wide range of aerospace and defense products and aftermarket services, including flight control systems, cabin interiors, connected aviation solutions, and simulation and training systems for civil, military, and commercial space customers. Pratt & Whitney supplies aircraft engines and auxiliary power units for commercial, military, business jet, and general aviation markets, alongside fleet management and aftermarket maintenance services. Raytheon delivers defensive and offensive threat detection, tracking, and mitigation solutions, including sensors, mission orchestration, satellite control products, and software for government and commercial customers.
The company was originally incorporated in 1934 and was formerly known as Raytheon Technologies Corporation before rebranding to RTX Corporation in July 2023. As a mega-cap stock in the GICS Industrials sector, RTX serves commercial, military, and government customers worldwide, combining propulsion systems, avionics, and defense electronics under one diversified business model.
- Pratt & Whitney GTF inspections pressure margins and free cash flow
- Raytheon missile demand surges on rising global defense budgets
- Collins Aerospace aftermarket recovery drives margin expansion
| Net Income: 7.26b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.77 > 1.0 |
| NWC/Revenue: 1.58% < 20% (prev 0.36%; Δ 1.23% < -1%) |
| CFO/TA 0.07 > 3% & CFO 11.1b > Net Income 7.26b |
| Net Debt (33.6b) to EBITDA (15.4b): 2.18 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.36b) vs 12m ago 0.95% < -2% |
| Gross Margin: 20.21% > 18% (prev 19.53%; Δ 0.68% > 0.5%) |
| Asset Turnover: 53.91% > 50% (prev 49.58%; Δ 4.33% > 0%) |
| Interest Coverage Ratio: 6.35 > 6 (EBIT TTM 11.0b / Interest Expense TTM 1.74b) |
| A: 0.01 (Total Current Assets 60.0b - Total Current Liabilities 58.6b) / Total Assets 170b |
| B: 0.34 (Retained Earnings 57.9b / Total Assets 170b) |
| C: 0.07 (EBIT TTM 11.0b / Avg Total Assets 168b) |
| D: 0.65 (Book Value of Equity 66.3b / Total Liabilities 102b) |
| Altman-Z'' = 2.28 = BBB |
| DSRI: 1.05 (Receivables 31.0b/26.7b, Revenue 90.4b/81.7b) |
| GMI: 0.97 (GM 19.53% / 20.21%) |
| AQI: 0.95 (AQ_t 0.54 / AQ_t-1 0.57) |
| SGI: 1.11 (Revenue 90.4b / 81.7b) |
| TATA: -0.02 (NI 7.26b - CFO 11.1b) / TA 170b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of July 08, 2026, the stock is trading at USD 200.85 with a total of 4,399,227 shares traded. Over the past week, the price has changed by +7.22%, over one month by +12.42%, over three months by +1.90% and over the past year by +39.84%.
Current recommended Stop Loss: 190.30 (which is 5.3% or 2.3 ATR below the current price).
RTX has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy RTX.
- StrongBuy: 12
- Buy: 4
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 215.7 | 7.4% |
P/E Trailing = 37.3127
P/E Forward = 27.6243
P/S = 2.9691
P/B = 3.8966
P/EG = 2.628
Revenue TTM = 90.4b USD
EBIT TTM = 11.0b USD
EBITDA TTM = 15.4b USD
Long Term Debt = 33.0b USD (from longTermDebt, last quarter)
Short Term Debt = 4.44b USD (from shortTermDebt, last quarter)
Debt = 40.5b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.52b
Net Debt = 33.6b USD (calculated: Debt 40.5b - CCE 6.82b)
Enterprise Value = 302b USD (268b + Debt 40.5b - CCE 6.82b)
Interest Coverage Ratio = 6.35 (Ebit TTM 11.0b / Interest Expense TTM 1.74b)
EV/FCF = 36.12x (Enterprise Value 302b / FCF TTM 8.36b)
FCF Yield = 2.77% (FCF TTM 8.36b / Enterprise Value 302b)
FCF Margin = 9.25% (FCF TTM 8.36b / Revenue TTM 90.4b)
Net Margin = 8.03% (Net Income TTM 7.26b / Revenue TTM 90.4b)
Gross Margin = 20.21% ((Revenue TTM 90.4b - Cost of Revenue TTM 72.1b) / Revenue TTM)
Gross Margin QoQ = 20.81% (prev 19.46%)
Tobins Q-Ratio = 1.77 (Enterprise Value 302b / Total Assets 170b)
Interest Expense / Debt = 4.30% (Interest Expense 1.74b / Debt 40.5b)
Taxrate = 18.22% (1.69b / 9.29b)
NOPAT = 9.02b (EBIT 11.0b * (1 - 18.22%))
Current Ratio = 1.02 (Total Current Assets 60.0b / Total Current Liabilities 58.6b)
Debt / Equity = 0.61 (Debt 40.5b / totalStockholderEquity, last quarter 66.3b)
Debt / EBITDA = 2.18 (Net Debt 33.6b / EBITDA 15.4b)
Debt / FCF = 4.02 (Net Debt 33.6b / FCF TTM 8.36b)
Total Stockholder Equity = 64.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.33% (Net Income 7.26b / Total Assets 170b)
RoE = 11.23% (Net Income TTM 7.26b / Total Stockholder Equity 64.6b)
RoCE = 11.31% (EBIT 11.0b / Capital Employed (Equity 64.6b + L.T.Debt 33.0b))
RoIC = 8.07% (NOPAT 9.02b / Invested Capital 112b)
WACC = 6.93% (E(268b)/V(309b) * Re(7.44%) + D(40.5b)/V(309b) * Rd(4.30%) * (1-Tc(0.18)))
Discount Rate = 7.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 67.42 | Cagr: 0.09%
[DCF] Terminal Value 77.97% ; FCFF base≈7.08b ; Y1≈8.12b ; Y5≈11.9b
[DCF] Fair Price = 108.5 (EV 180b - Net Debt 33.6b = Equity 146b / Shares 1.35b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.78 | EPS CAGR: 11.86% | SUE: 2.48 | # QB: 1
Revenue Correlation: 96.98 | Revenue CAGR: 11.80% | SUE: 0.95 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.66 | Chg30d=+0.28% | Revisions=+0% | Analysts=18
EPS next Quarter (2026-09-30): EPS=1.73 | Chg30d=+0.13% | Revisions=+0% | Analysts=18
EPS current Year (2026-12-31): EPS=6.91 | Chg30d=+0.20% | Revisions=+40% | GrowthEPS=+9.9% | GrowthRev=+6.2%
EPS next Year (2027-12-31): EPS=7.58 | Chg30d=+0.28% | Revisions=+17% | GrowthEPS=+9.6% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: +25% (up=6, down=3)